Falling oil prices will cut drug industry materials, manufacturing and logistics costs, and protect firms at risk of generic competition in 2015 according to one industry analyst.
Specialty chemicals group H&R Wasag witnessed tremendous growth
in the first quarter of 2006, as stable crude oil prices allowed it
to increase prices and volumes in the pharmaceutical raw materials
it sells.
German specialty chemicals group, H&R Wasag, increased its
sales and earnings in the third quarter of this year, helped by its
in-house refinery operations that allow it to counter the steady
rise in costs arising from crude oil...
German specialty chemicals group, H&R Wasag, increased its
sales and earnings in the first half of the year, helped by its
in-house refinery operations that allow it to anticipate and react
early to changing oil prices.